SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 40 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $135,000 | -4.9% | 112,719 | 0.0% | 0.16% | 0.0% |
| Q2 2017 | $142,000 | +4.4% | 112,719 | 0.0% | 0.16% | +10.7% |
| Q1 2017 | $136,000 | -21.8% | 112,719 | +27.5% | 0.15% | -19.9% |
| Q4 2016 | $174,000 | -8.4% | 88,411 | +51.3% | 0.19% | +3.3% |
| Q3 2016 | $190,000 | +22.6% | 58,435 | +34.5% | 0.18% | +24.1% |
| Q2 2016 | $155,000 | +6.9% | 43,435 | +44.8% | 0.14% | +9.8% |
| Q1 2016 | $145,000 | -42.7% | 30,000 | -30.1% | 0.13% | -33.3% |
| Q4 2015 | $253,000 | +50.6% | 42,945 | +51.8% | 0.20% | +46.7% |
| Q3 2015 | $168,000 | -51.2% | 28,295 | +11.9% | 0.14% | -42.3% |
| Q2 2015 | $344,000 | -2.0% | 25,295 | -7.5% | 0.23% | -10.7% |
| Q1 2015 | $351,000 | +67.9% | 27,350 | +34.4% | 0.26% | +131.9% |
| Q4 2014 | $209,000 | – | 20,350 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,492,975 | $3,597,974,000 | 1.05% |
| &PARTNERS | 51,961 | $42,000 | 0.06% |
| Glassman Wealth Services | 72,366 | $58,000 | 0.02% |
| Sigma Planning Corp | 385,737 | $309,000 | 0.02% |
| HBK Sorce Advisory LLC | 100,000 | $80,000 | 0.01% |
| Fore Capital, LLC | 56,300 | $45,000 | 0.01% |
| WealthTrust Axiom LLC | 17,320 | $13,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 40,800 | $33,000 | 0.01% |
| Semmax Financial Advisors Inc. | 7,290 | $6,000 | 0.00% |
| Ausdal Financial Partners, Inc. | 10,025 | $9,000 | 0.00% |